About SELINEXOR
            
            Class: | Antineoplastic agent, Exportin 1 inhibitor  
Use: | Treatment of multiple myeloma in combination with dexamethasone; treatment of diffuse large B-cell lymphoma (DLBCL) in patients who have received at least two prior therapies  
Adult dose: | 60 mg orally once weekly for multiple myeloma; 100 mg orally twice weekly for DLBCL  
Pediatric dose: | Safety and efficacy have not been established in pediatric patients  
Side effects: | Nausea, vomiting, diarrhea, fatigue, anorexia, weight loss
         
        
            
                
                
                    
                        Drug Class
                    
                    Antineoplastic agent, Exportin 1 inhibitor
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of multiple myeloma in combination with dexamethasone; treatment of diffuse large B-cell lymphoma (DLBCL) in patients who have received at least two prior therapies
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from moisture and light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Stemline Therapeutics, B.V.[Amsterdam;Netherlands, Netherlands
                    
                    
                    Package Size
                    32's (32 film Coated tablets)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 106142.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        60 mg orally once weekly for multiple myeloma; 100 mg orally twice weekly for DLBCL
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy have not been established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, vomiting, diarrhea, fatigue, anorexia, weight loss, thrombocytopenia, neutropenia, anemia
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to selinexor or any component of the formulation; pregnancy (Category X)
         
        
        
            
                Important Warnings
            
            Risk of severe thrombocytopenia and neutropenia; monitor complete blood counts regularly; may cause fetal harm; use effective contraception during treatment and for at least 1 month after the last dose
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.